Stay updated on Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.

Latest updates to the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical study on inhaled treprostinil for pulmonary hypertension, including objectives, study design, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference31%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check87 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
Stay in the know with updates to Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.